The enhancement of Raf-1 kinase activity by knockdown of Spry2 is associated with high sensitivity to paclitaxel in v-Ha-ras-transformed NIH 3T3 fibroblasts

Molecular and Cellular Biochemistry

Volumn 332, Issue 1-2, 2009, Pages 189-197

  Ahn, Jun Ho ^a   Eum, Ki Hwan ^a   Lee, Michael ^a  

^a SolarLight Ltd   (South Korea)

Author keywords

Paclitaxel; Raf 1 kinase; SiRNA; Sprouty proteins

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PACLITAXEL; RAF PROTEIN; RAS PROTEIN; SMALL INTERFERING RNA; SPROUTY PROTEIN;

APOPTOSIS; ARTICLE; CELL STRAIN 3T3; CELL TRANSFORMATION; CHEMOSENSITIVITY; CONTROLLED STUDY; CPG ISLAND; DOWN REGULATION; DRUG RESISTANCE; ENZYME ACTIVITY; EXON; HUMAN; HUMAN CELL; INHIBITION KINETICS; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN METHYLATION; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL LINE, TRANSFORMED; CPG ISLANDS; DNA METHYLATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLASTS; GENES, RAS; MAP KINASE SIGNALING SYSTEM; MEMBRANE PROTEINS; MICE; NIH 3T3 CELLS; PACLITAXEL; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-RAF; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 70450257737     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-009-0191-5     Document Type: Article

References (47)

1. S Haldar J Chintapalli CM Croce 1996 Taxol induces bcl-2 phosphorylation and death of prostate cancer cells Cancer Res 56 1253 1255 8640809
2. LF Lee JS Haskill N Mukaida K Matsushima JP Ting 1997 Identification of tumor-specific paclitaxel (Taxol)-responsive regulatory elements in the interleukin-8 promoter Mol Cell Biol 17 5097 5105 9271387
3. J Zhou P Giannakakou 2005 Targeting microtubules for cancer chemotherapy Curr Med Chem Anticancer Agents 5 65 71 10.2174/1568011053352569 15720262 (Pubitemid 40081295)
4. BT McGrogan B Gilmartin DN Carney A McCann 2008 Taxanes, microtubules and chemoresistant breast cancer Biochim Biophys Acta 1785 96 132 18068131
5. MM Gottesman 2002 Mechanisms of cancer drug resistance Annu Rev Med 53 615 627 10.1146/annurev.med.53.082901.103929 11818492 (Pubitemid 34177898)
6. HK Berrieman MJ Lind L Cawkwell 2004 Do beta-tubulin mutations have a role in resistance to chemotherapy? Lancet Oncol 5 158 164 10.1016/S1470- 2045(04)01411-1 15003198 (Pubitemid 38262847)
7. CA Burkhart M Kavallaris S Band Horwitz 2001 The role of beta-tubulin isotypes in resistance to antimitotic drugs Biochim Biophys Acta 1471 O1 O9 11342188
8. A Goncalves D Braguer K Kamath L Martello C Briand S Horwitz L Wilson MA Jordan 2001 Resistance to Taxol in lung cancer cells associated with increased microtubule dynamics Proc Natl Acad Sci USA 98 11737 11742 10.1073/pnas. 191388598 11562465 (Pubitemid 32928798)
9. DK Morrison RE Cutler 1997 The complexity of Raf-1 regulation Curr Opin Cell Biol 9 174 179 10.1016/S0955-0674(97)80060-9 9069260 (Pubitemid 27135984)
10. JA McCubrey LS Steelman WH Chappell SL Abrams EW Wong F Chang B Lehmann DM Terrian M Milella A Tafuri F Stivala M Libra J Basecke C Evangelisti AM Martelli RA Franklin 2007 Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance Biochim Biophys Acta 1773 1263 1284 10.1016/j.bbamcr.2006.10.001 17126425 (Pubitemid 47125967)
11. L is mediated by JNK and occurs in parallel with inactivation of the Raf-1/MEK/ERK cascade J Biol Chem 275 29980 29985 10.1074/jbc.M003776200 10913135
12. 53 requires c-raf-1 Cancer Res 55 4623 4626 7553639
13. MV Blagosklonny T Schulte P Nguyen J Trepel LM Neckers 1996 Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involved c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway Cancer Res 56 1851 1854 8620503
14. MV Blagosklonny P Giannakakou WS El-Deiry DG Kingston PI Higgs L Neckers T Fojo 1997 Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death Cancer Res 57 130 135 8988053
15. Y Kalechman DL Longo R Catane A Shani M Albeck B Sredni 2000 Synergistic anti-tumoral effect of paclitaxel (Taxol)+AS101 in a murine model of B16 melanoma: association with ras-dependent signal-transduction pathways Int J Cancer 86 281 288 10.1002/(SICI)1097-0215(20000415)86:2<281::AID-IJC20>3. 0.CO;2-X 10738258 (Pubitemid 30180826)
16. S Mabuchi M Ohmichi A Kimura K Hisamoto J Hayakawa Y Nishio K Adachi K Takahashi E Arimoto-Ishida Y Nakatsuji K Tasaka Y Murata 2002 Inhibition of phosphorylation of BAD and Raf-1 by Akt sensitizes human ovarian cancer cells to paclitaxel J Biol Chem 277 33490 33500 10.1074/jbc.M204042200 12087097 (Pubitemid 34984873)
17. A Rasouli-Nia D Liu S Perdue RA Britten 1998 High Raf-1 kinase activity protects human tumor cells against paclitaxel-induced cytotoxicity Clin Cancer Res 4 1111 1116 9607567
18. wt human ovarian cancer cells Oncol Rep 7 821 825 10854551
19. JTJ Lee LS Steelman JA McCubrey 2005 Modulation of Raf/MEK/ERK kinase activity does not affect the chemoresistance profile of advanced prostate cancer cells Int J Oncol 26 1637 1644 15870880
20. A Sasaki T Taketomi R Kato K Saeki A Nonami M Sasaki M Kuriyama N Saito M Shibuya A Yoshimura 2003 Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1 Nat Cell Biol 5 427 432 10.1038/ncb978 12717443 (Pubitemid 36592265)
21. P Yusoff D-H Lao SH Ong ESM Wong J Lim TL Lo F Leong CW Fong GR Guy 2002 Sprouty2 inhibits the Ras/MAP kinase pathway by inhibiting the activation of Raf J Biol Chem 277 3195 3201 10.1074/jbc.M108368200 11698404 (Pubitemid 34953181)
22. N Hacohen S Kramer D Sutherland Y Hiromi MA Krasnow 1998 Sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways Cell 92 253 263 10.1016/S0092-8674(00)80919-8 9458049 (Pubitemid 28073048)
23. HJ Kim D Bar-Sagi 2004 Modulation of signalling by Sprouty: a developing story Nat Rev Mol Cell Biol 5 441 450 10.1038/nrm1400 15173823 (Pubitemid 38745494)
24. P Lito BD Mets DM Appledorn VM Maher JJ McCormick 2008 Sprouty 2 regulates DNA damage-induced apoptosis in Ras-transformed human fibroblasts J Biol Chem 284 848 854 10.1074/jbc.M808045200 19008219
25. F Edwin TB Patel 2008 A novel role of Sprouty2 in regulating cellular apoptosis J Biol Chem 283 3181 3190 10.1074/jbc.M706567200 18070883
26. M Lee 2006 Raf-1 kinase activation is uncoupled from downstream MEK/ERK pathway in cells treated with Src tyrosine kinase inhibitor PP2 Biochem Biophys Res Commun 350 450 456 10.1016/j.bbrc.2006.09.067 17010316 (Pubitemid 44498657)
27. 2 J Biol Chem 279 48692 48701 10.1074/jbc.M403132200 15356004 (Pubitemid 39625745)
28. RR Tice E Agurell D Anderson B Burlinson A Hartmann H Kobayashi Y Miyamae E Rojas JC Ryu YF Sasaki 2000 Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing Environ Mol Mutagen 35 206 221 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J 10737956 (Pubitemid 30196665)
29. HW Cheung MT Ling SW Tsao YC Wong X Wang 2004 Id-1-induced Raf/MEK pathway activation is essential for its protective role against taxol-induced apoptosis in nasopharyngeal carcinoma cells Carcinogenesis 25 881 887 10.1093/carcin/bgh087 14742319 (Pubitemid 38898634)
30. K Torres SB Horwitz 1998 Mechanisms of Taxol-induced cell death are concentration dependent Cancer Res 58 3620 3626 9721870
31. AB McKie DA Douglas S Olijslagers J Graham MM Omar R Heer VJ Gnanapragasam CN Robson HY Leung 2005 Epigenetic inactivation of the human sprouty2 (hSPRY2) homologue in prostate cancer Oncogene 24 2166 2174 10.1038/sj.onc.1208371 15735753 (Pubitemid 40516583)
32. WP McGuire EK Rowinsky NB Rosenshein FC Grumbine DS Ettinger DK Armstrong RC Donehower 1989 Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms Ann Intern Med 111 273 279 2569287
33. FA Holmes RS Walters RL Theriault AD Forman LK Newton MN Raber AU Buzdar DK Frye GN Hortobagyi 1991 Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer J Natl Cancer Inst 83 1797 1805 10.1093/jnci/83.24.1797-a 1683908
34. JH Schiller D Harrington CP Belani C Langer A Sandler J Krook J Zhu D Johnson 2002 Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer N Engl J Med 346 92 98 10.1056/NEJMoa011954 11784875 (Pubitemid 34438899)
35. MV Blagosklonny T Fojo 1999 Molecular effects of paclitaxel: myths and reality (a critical review) Int J Cancer 83 151 156 10.1002/(SICI)1097- 0215(19991008)83:2<151::AID-IJC1>3.0.CO;2-5 10471519 (Pubitemid 29449089)
36. N Ahmed S Dasari SS Srivastava A Sneh A Ahmad M Islam Khan MV Krishnasastry 2008 Taxol and 10-deacetylbaccatinIII induce distinct changes in the dynamics of caveolae FEBS Lett 582 3595 3600 10.1016/j.febslet.2008.09.029 18817775
37. M Lee WS Koh SS Han 2003 Down-regulation of Raf-1 kinase is associated with paclitaxel resistance in human breast cancer MCF-7/Adr cells Cancer Lett 193 57 64 10.1016/S0304-3835(02)00722-X 12691824 (Pubitemid 36412079)
38. JM Davis PM Navolanic CR Weinstein-Oppenheimer LS Steelman W Hu M Konopleva MV Blagosklonny JA McCubrey 2003 Raf-1 and Bcl-2 induce distinct and common pathways that contribute to breast cancer drug resistance Clin Cancer Res 9 1161 1170 12631622
39. EM Eves P Shapiro K Naik UR Klein N Trakul MR Rosner 2006 Raf kinase inhibitory protein regulates aurora B kinase and the spindle checkpoint Mol Cell 23 561 574 10.1016/j.molcel.2006.07.015 16916643 (Pubitemid 44205493)
40. JA McCubrey LS Steelman SL Abrams JT Lee F Chang FE Bertrand PM Navolanic DM Terrian RA Franklin AB D'Assoro JL Salisbury MC Mazzarino F Stivala M Libra 2006 Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance Adv Enzyme Regul 46 249 279 10.1016/j.advenzreg.2006.01.004 16854453 (Pubitemid 44301348)
41. M Mikula M Schreiber Z Husak L Kucerova J Ruth R Wieser K Zatloukal H Beug EF Wagner M Baccarini 2001 Embryonic lethality and fetal liver apoptosis in mice lacking the c-raf-1 gene EMBO J 20 1952 1962 10.1093/emboj/20.8.1952 11296228 (Pubitemid 32397397)
42. I Gross B Bassit M Benezra JD Licht 2001 Mammalian sprouty proteins inhibit cell growth and differentiation by preventing ras activation J Biol Chem 276 46460 46468 10.1074/jbc.M108234200 11585837
43. R Bicknell AL Harris 2004 Novel angiogenic signaling pathways and vascular targets Annu Rev Pharmacol Toxicol 44 219 238 10.1146/annurev.pharmtox. 44.101802.121650 14744245 (Pubitemid 38263840)
44. SH Lee DJ Schloss L Jarvis MA Krasnow JL Swain 2001 Inhibition of angiogenesis by a mouse sprouty protein J Biol Chem 276 4128 4133 10.1074/jbc.M006922200 11053436
45. C-C Lee AJ Putnam CK Miranti M Gustafson LM Wang GF Vande Woude CF Gao 2004 Overexpression of sprouty 2 inhibits HGF/SF-mediated cell growth, invasion, migration, and cytokinesis Oncogene 23 5193 5202 10.1038/sj.onc.1207646 15122328 (Pubitemid 38980352)
46. CW Fong MS Chua AB McKie SH Ling V Mason R Li P Yusoff TL Lo HY Leung SK So GR Guy 2006 Sprouty 2, an inhibitor of mitogen-activated protein kinase signaling, is down-regulated in hepatocellular carcinoma Cancer Res 66 2048 2058 10.1158/0008-5472.CAN-05-1072 16489004 (Pubitemid 43294913)
47. MM Cornwell DE Smith 1993 A signal transduction pathway for activation of the mdr1 promoter involves the proto-oncogene c-raf kinase J Biol Chem 268 15347 15350 8101839